| Literature DB >> 33788031 |
Andrea Ruzzenente1, Andrea Ciangherotti2, Luca Aldrighetti3, Giuseppe Maria Ettorre4, Luciano De Carlis5,6, Alessandro Ferrero7, Raffaele Dalla Valle8, Giuseppe Tisone9, Alfredo Guglielmi2.
Abstract
BACKGROUND: Although isolated caudate lobe (CL) liver resection is not a contraindication for minimally invasive liver surgery (MILS), feasibility and safety of the procedure are still poorly investigated. To address this gap, we evaluate data on the Italian prospective maintained database on laparoscopic liver surgery (IgoMILS) and compare outcomes between MILS and open group.Entities:
Keywords: Caudate lobe; Minimally invasive liver surgery; Multi-institutional; Propensity score matched
Mesh:
Year: 2021 PMID: 33788031 PMCID: PMC8758628 DOI: 10.1007/s00464-021-08434-w
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Fig. 1A surgical case of isolated MILS caudate lobe resection for HCC. Surgical case of isolated caudate lobe resection for 3 cm HCC (A), patient was positioned in French position with operating surgeon standing between patients’ legs, the scheme illustrating the position of the of trocars (B). Mobilization of caudate lobe from inferior vena cava, short hepatic veins secured with clips (C). Liver transection with ultrasonic aspirator (D)
Demographics and preoperative data
| Variables | Before propensity matching score | After propensity matching score | ||||
|---|---|---|---|---|---|---|
| S1-MILS | S1-open | S1-MILS | S1-open | |||
| 47 | 177 | 42 | 43 | |||
| Gender male (%) | 24 (51.1) | 109 (61.6) | n.s | 20 (47.6) | 24 (55.8) | n.s |
| Age, mean, years (SD) | 60.7 (15.7) | 58.4 (14.5) | n.s | 60.8 (15.9) | 54.9 (15.7) | n.s |
| BMI, mean (SD) | 25.4 (4.1) | 25.3 (4.0) | n.s | 25.3 (4.2) | 24.9 (4.2) | n.s |
| Morbidities | ||||||
| Arterial hypertension (%) | 16 (35.6) | 48 (28.7) | n.s | 15 (36.6) | 7 (16.3) | 0.03 |
| COPD (%) | 3 (6.8) | 9 (5.4) | n.s | 3 (7.3) | 3 (7.0) | n.s |
| Diabetes (%) | 5 (11.4) | 23 (13.9) | n.s | 5 (12.2) | 5 (11.6) | n.s |
| Dyslipidemia (%) | 3 (6.8) | 23 (13.8) | n.s | 3 (7.3) | 7 (16.3) | n.s |
| Ischemic heart disease (%) | 3 (6.8) | 14 (8.4) | n.s | 3 (7.3) | 5 (11.6) | n.s |
| HBV infection (%) | 6 (13.6) | 7 (4.2) | 0.034 | 5 (11.6) | 5 (12.2) | n.s |
| HCV infection (%) | 7 (16.3) | 11 (6.7) | n.s | 7 (17.5) | 8 (18.6) | n.s |
| Alcohol related liver dis. (%) | 3 (6.8) | 9 (5.5) | n.s | 3 (7.3) | 2 (4.7) | n.s |
| Previous chemotherapy (%) | 16 (36.4) | 49 (30.6) | n.s | 15 (36.6) | 8 (18.6) | n.s |
| Liver disease | < 0.001 | n.s | ||||
| Normal (%) | 24 (51.1) | 88 (49.7) | 21 (50.0) | 22 (51.2) | ||
| Steatosis (%) | 6 (12.8) | 26 (14.7) | 6 (14.0) | 6 (14.3) | ||
| Fibrosis (%) | 6 (12.8) | 5 (2.8) | 5 (11.9) | 4 (9.3) | ||
| Cirrhosis (%) | 10 (21.3) | 16 (9.0) | 10 (23.8) | 11 (25.6) | ||
| Missing (%) | 1 (2.1) | 42 (23.7) | 0 (0.0) | 0 (0.0) | ||
| Pathology | 0.020 | n.s | ||||
| CRLM (%) | 12 (25.5) | 87 (49.2) | 11 (26.2) | 13 (30.2) | ||
| ICC (%) | 0 (0.0) | 5 (2.9) | 0 (0.0) | 1 (2.3) | ||
| HCC (%) | 17 (36.2) | 29 (16.4) | 16 (38.1) | 13 (30.2) | ||
| NCRLM (%) | 4 (8.5) | 15 (8.5) | 3 (7.1) | 3 (7.0) | ||
| Benign (%) | 13 (27.7) | 39 (22.2) | 12 (28.6) | 13 (30.2) | ||
| Missing (%) | 1 (2.1) | 2 (1.1) | 0 | 0 | ||
| Previous surgery | ||||||
| Cholecystectomy (%) | 4 (8.5) | 19 (13.5) | n.s | 3 (7.1) | 4 (9.3) | n.s |
| Hepatic resection (%) | 5 (10.6) | 27 (15.3) | n.s | 4 (9.5) | 4 (9.3) | n.s |
| Colonic resection (%) | 9 (19.1) | 44 (31.4) | n.s | 9 (21.4) | 11 (25.6) | n.s |
| Tumor size, mean, mm (SD) | 36.9 (29.7) | 31.1 (20.1) | n.s | 35.7 (29.7) | 37.7 (21.9) | n.s |
Intraoperative and postoperative data
| Variables | Before propensity matching score | After propensity matching score | ||||
|---|---|---|---|---|---|---|
| S1-MILS | S1-open | S1-MILS | S1-open | |||
| 47 | 177 | 42 | 43 | |||
| Type of surgical procedure | 0.022 | n.s | ||||
| Combined Spiegel’s lobe + paracaval portion (%) | 15 (31.9) | 91 (51.4) | 13 (31.0) | 16 (37.2) | ||
| Limited Spiegel’s lobe (%) | 30 (63.8) | 86 (48.6) | 29 (69.0) | 27 (62.8) | ||
| Missing (%) | 2 (4.3) | 0 | 0 | 0 | ||
| Associate surgical procedure | ||||||
| Other liver resection (%) | 13 (27.6) | 51 (28.7) | n.s | 11 (26.2) | 5 (11.6) | n.s |
| Cholecystectomy (%) | 6 (13.3) | 25 (14.1) | n.s | 6 (14.3) | 7 (16.3) | n.s |
| Colonic resection (%) | 3 (6.7) | 9 (5.1) | n.s | 3 (7.1) | 1 (2.3) | n.s |
| Pringle maneuver | < 0.001 | < 0.001 | ||||
| No (%) | 31 (66.6) | 31 (17.6) | 26 (61.9) | 10 (23.3) | ||
| Intermittent (%) | 14 (29.8) | 118 (67.0) | 14 (30.4) | 23 (61.9) | ||
| Continuous (%) | 0 | 2 (1.1) | 0 (0.0) | 1 (2.3) | ||
| Missing (%) | 2 (4.3) | 25 (14.2) | 2 (4.8) | 0 | ||
| Intraoperative data | ||||||
| Conversion to open (%) | 3 (6.4) | – | 3 (7.1) | – | ||
| Blood losses, mean, mL (SD) | 175 (153) | 343 (292) | < 0.001 | 173 (154) | 290 (186) | 0.003 |
| Blood transfusions (%) | 0 (0.0%) | 17 (10.0) | 0.013 | 0 (0.0) | 2 (4.8) | n.s |
| Drainage (%) | 35 (74.5) | 173 (97.7) | < 0.001 | 30 (71.4%) | 42 (97.7) | 0.001 |
| Operation time mean, min (SD) | 309 (116) | 235 (120) | 0.001 | 298 (126) | 238 (123) | 0.038 |
| Postoperative data | ||||||
| R1 resectiona (%) | 4/33 (12.1) | 14/128 (10.9) | n.s | 4/30 (13.3) | 3/30 (10.0) | n.s |
| Blood transfusions (%) | 3 (6.4) | 12 (8.6) | n.s | 3 (7.1) | 6 (15.8) | n.s |
| In-hospital Mortality (%) | 0 | 0 | n.s | 0 | 0 | n.s |
| Overall complications (%) | 8 (17.0) | 34 (19.9) | n.s | 6 (14.3) | 3 (7.0) | n.s |
| Ascites (%) | 0 | 3 (1.7) | n.s | 0 | 0 | n.s |
| Abdominal collection (%) | 1 (2.1) | 8 (4.7) | n.s | 1 (2.4) | 2 (4.7) | n.s |
| Biliary fistula (%) | 0 | 7 (4.1) | n.s | 0 | 1 (2.6) | n.s |
| Cardiological (%) | 1 (2.1) | 2 (1.4) | n.s | 1 (2.4) | 1 (2.6) | n.s |
| Bowel complications (%) | 1 (2.1) | 3 (2.1) | n.s | 0 | 0 | n.s |
| Pneumoniae (%) | 1 (2.1) | 3 (2.1) | n.s | 0 | 0 | n.s |
| Pleural effusions (%) | 1 (2.1) | 9 (5.2) | n.s | 1 (2.4) | 0 | n.s |
| Wound infections (%) | 1 (2.1) | 2 (1.4) | n.s | 0 | 0 | n.s |
| Severe complications (Dindo–Clavien ≥ 3) (%) | 0 | 12 (6.8) | n.s | 0 | 3 (7.0) | n.s |
| CCI, mean (SD) | 13.7 (6.1) | 23.4 (11.7) | 0.03 | 13.3 (6.0) | 29.8 (6.3) | 0.006 |
| Length of stay, mean, days (SD) | 4.9 (3.7) | 8.7 (9.9) | 0.01 | 4.7 (2.2) | 7.4 (9.2) | n.s |
aReferred only to malign tumors
Subgroup analysis according to the surgical procedure of S1 resection, resection limited to Spiegel lobe (S1-S) and resection of the Spiegel lobe extended to the paracaval portion and complete/partial resection of caudate process (S1-S + P)
| Limited Spiegel’s lobe (S1-S) | Spiegel’s lobe and paracaval portion (S1-S + P) | ||||||
|---|---|---|---|---|---|---|---|
| S1-MILS | S1-open | S1-MILS | S1-open | ||||
| 30 | 86 | 15 | 91 | ||||
| Pringle maneuver | 0.006 | n.s | |||||
| No (%) | 20 (66.7) | 15 (17.6) | 8 (53.3) | 16 (18.0) | |||
| Intermittent (%) | 10 (33.3) | 64 (75.3) | 5 (33.3) | 54 (60.7) | |||
| Continuous (%) | 0 | 0 | 0 | 2 (2.2) | |||
| Missing (%) | 0 | 6 (7.1) | 2 (13.3) | 17 (19.1) | |||
| Intraoperative data | |||||||
| Conversion to open (%) | 2 (6.7) | 0 | n.s | 1 (6.7) | 0 | n.s | |
| Blood losses, mean, mL (SD) | 197.7 (158.1) | 346.2 (307.8) | 0.014 | 234 (127.4) | 340 (277.2) | n.s | |
| Drainage (%) | 20 (66.7) | 83 (97.6) | < 0.001 | 13 (86.7) | 86 (97.7) | n.s | |
| Operation time mean, min (SD) | 294 (110) | 240 (127) | 0.044 | 327 (125) | 216 (110) | 0.003 | |
| Postoperative data | |||||||
| R1 resectiona (%) | 2/20 (10.0) | 5/69 (7.2) | n.s | 2/11 (18.2) | 9/64 (14.1) | n.s | |
| Tumor size, mean, mm (SD) | 37.1 (32.3) | 38.2 (87.1) | n.s | 35.9 (25.0) | 33.9 (20.5) | n.s | |
| Blood transfusions (%) | 2 (6.7) | 7 (10.8) | n.s | 1 (6.7) | 5 (6.7) | n.s | |
| In-hospital mortality (%) | 0 | 0 | 0 | 0 | |||
| Overall complications (%) | 5 (16.7) | 13 (15.7) | n.s | 3 (16.7) | 21 (15.7) | n.s | |
| Ascites (%) | 0 | 2 (2.4) | n.s | 0 | 1 (1.1) | n.s | |
| Abdominal collection (%) | 1 (3.3) | 0 | n.s | 0 | 6 (6.8) | n.s | |
| Biliary fistula (%) | 0 | 2 (2.4) | n.s | 0 | 5 (5.7) | n.s | |
| Cardiological (%) | 1 (3.3) | 2 (2.4) | n.s | 0 | 2 (2.4) | n.s | |
| Bowel complications (%) | 0 | 2 (2.4) | n.s | 1 (6.7) | 1 (1.3) | n.s | |
| Pneumoniae (%) | 0 | 1 (6.7) | n.s | 1 (6.7) | 3 (3.9) | n.s | |
| Pleural effusions (%) | 1 (3.3) | 2 (2.4) | n.s | 7 (8.0) | n.s | ||
| Wound infections (%) | 0 | 1 (1.5) | n.s | 1 (6.7) | 1 (1.3) | n.s | |
| Severe complications (Dindo Clavien ≥ 3) (%) | 0 | 4 (4.7) | n.s | 0 | 8 (9.0) | n.s | |
| CCI, mean (SD) | 11.8 (5.3) | 22.2 (11.2) | n.s | 12.7 (7.1) | 24.2 (12.3) | n.s | |
| Length of stay, mean days (SD) | 4.63 (2.2) | 8.0 (9.8) | n.s | 4.67 (2.3) | 9.43 (10.1) | n.s | |
Intraoperative and postoperative data
aReferred only to malign tumors
Literature review
| First author | Year | Country | Type | Sample size | Surgical technique | Type of lesions | Morbidity/mortality | Operation time |
|---|---|---|---|---|---|---|---|---|
| Koffron | 2007 | USA | Case series | 7 | MILS | 5 benign, 2 malignant | NR/0 | NR |
| Chen | 2013 | China | Case series | 8 | MILS | malignant | 0/0 | 201–345 |
| Araki | 2016 | USA | Case-match | 15 | MILS | 13 benign, 2 malignant | 6.6%/0 | 60–480 |
| Oh | 2016 | Korea | Case series | 6 | MILS | malignant | 0/0 | 168–615 |
| Salloum | 2016 | France | Case series | 5 | MILS | 4 benign, 1 malignant | 0/0 | 50–700 |
| Chai | 2018 | China | Case series | 6 | MILS | 2 benign, 4 malignant | 33.3%/0 | 173–300 |
| Jin | 2018 | China | Case series | 12 | MILS | 5 benign, 7 malignant | 0/0 | 140.8 (Mean) |
| Xu | 2020 | China | Case-match + PSM | 19 (MILS) vs 112 (open) | MILS vs open | 11 benign, 8 malignant (MILS) vs 57 benign, 55 malignant (open) | 11.1%/0 (MILS) vs 11.1%/0 (open) | 128.5–219 vs 163.75–238 |
| Cappelle | 2020 | Belgium, Norway, The Netherlands | Case series | 32 | MILS | 5 benign, 27 malignant | 6.3% (severe)/0 | 29–440 |
| Current study | 2020 | Italy | Case-match + PSM | 47 (MILS) vs 177 (open) | MILS vs open | 13 benign, 34 malignant (MILS) vs 38 benign, 139 malignant (open) | 14.3%/0 (MILS) vs 7.0%/0 (open) | 309 (mean) 235 (mean) vs |